Regeneron Pharmaceuticals reported $405.6M in Selling and Administration Expenses for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 2.84B 389M
Acceleron Pharma XLRN:US $ 31.06M 4.85M
Agenus AGEN:US $ 16.35M 3.68M
Agios Pharmaceuticals AGIO:US $ 33.55M 6.23M
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
Alimera Sciences ALIM:US $ 8.23M 212K
Alnylam Pharmaceuticals ALNY:US $ 154.9M 11.39M
Amgen AMGN:US $ 1.25B 519M
Astellas Pharma 4503:JP 141.27B 20.36B
AstraZeneca AZN:LN 2.5B 129M
Biogen BIIB:US $ 637.3M 42.3M
Biomarin Pharmaceutical BMRN:US $ 174.32M 11.71M
Bluebird Bio BLUE:US $ 86.87M 9.9M
Bristol Myers Squibb BMY:US $ 1.67B 1.05B
Eli Lilly And LLY:US $ 1.58B 22.1M
Esperion Therapeutics ESPR:US $ 61.06M 491K
Gilead Sciences GILD:US $ 1.06B 675M
GlaxoSmithKline GSK:LN 2.32B 609M
Intercept Pharmaceuticals ICPT:US $ 59.28M 11.31M
IONIS PHARMACEUT IONS:US $ 61.2M 77.67M
Johnson & Johnson JNJ:US $ 6.07B 641M
Kyowa Hakko Kirin 4151:JP 29.02B 6.96B
Merk MRK:US $ 2.41B 663M
Moderna Inc MRNA:US 77M 1.99M
Neurocrine Biosciences NBIX:US $ 129M 22.5M
Novartis NVS:US 3.71B 190M
Novartis NOVN:VX 3.52B 388M
Opthea Ltd OPT:AU 7.51M 4.2M
Puma Biotechnology PBYI:US $ 28.24M 368K
Regeneron Pharmaceuticals REGN:US $ 405.6M 102.1M
Sarepta Therapeutics SRPT:US $ 71.13M 14.92M
Seattle Genetics SGEN:US $ 159.84M 1.48M
Teva Pharmaceutical TEVA:IT 848M 117M
Ultragenyx Pharmaceutical RARE:US $ 53.26M 2.22M
United Therapeutics UTHR:US $ 115.7M 43M
Vertex Pharmaceuticals VRTX:US $ 192.08M 19.77M
YTE INCY:US $ 153.79M 13.19M